Clinical Trial Update: Predictive Value of FDG-PET-CT Scans for Patients With Lung Cancer Receiving Concurrent Chemo-Radiation [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating FDG-PET-CT scans to predict outcomes in lung cancer patients receiving concurrent chemoradiation has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer
• Small Cell Lung Cancer

Snippet

Sponsor: Maastricht Radiation Oncology | Conditions: Lung Cancer, SCLC | Phase 3 | Status: TERMINATED